Crossref journal-article
Oxford University Press (OUP)
The Journal of Immunology (286)
Abstract

Abstract One of the most disturbing features of hepatitis C virus (HCV) is its long-term persistence in the host. One hypothesis to explain this phenomenon is that HCV escapes immune recognition through its intrinsic hypermutability. To determine whether immunodominant T cell epitopes derived from HCV nonstructural 3 (NS3) protein might be subject to sequence variations leading to escape mutants, we examined sequence variations of one IL-2-producing epitope, NS3358–375, and one IL-10-producing epitope, NS3505–521. By PCR amplification, cloning, and sequencing, we observed significant sequence variations in the two epitopes, although the selection intensity for each epitope was different. For NS3358–375, more variants were observed, and for NS3505–521, fewer mutations were observed. Moreover, functional studies revealed that three NS3358–375 and one NS3505–521 variants failed to stimulate T cell proliferation, and two other NS3358–375 and NS3505–521 variants weakly stimulated T cell responses. Our results are consistent with immune selection of viral variants at the epitope level, which may enable HCV to evade host defenses over time.

Bibliography

Wang, H., & Eckels, D. D. (1999). Mutations in Immunodominant T Cell Epitopes Derived from the Nonstructural 3 Protein of Hepatitis C Virus Have the Potential for Generating Escape Variants That May Have Important Consequences for T Cell Recognition. The Journal of Immunology, 162(7), 4177–4183.

Authors 2
  1. Huiru Wang (first)
  2. David D. Eckels (additional)
References 34 Referenced 73
  1. Choo, Q. L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359 (10.1126/science.2523562)
  2. Mosmann, T. R., R. L. Coffman. 1998. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145 (10.1146/annurev.iy.07.040189.001045)
  3. Muller, H. M., E. Pfaff, T. Goeser, B. Kallinowski, C. Solbach, L. Theilmann. 1993. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J. Gen. Virol. 74: 669 (10.1099/0022-1317-74-4-669)
  4. Sherman, P. A., P. V. Basta, J. P. Ting. 1987. Upstream DNA sequences required for tissue-specific expression of the HLA-DR α gene. Proc. Natl. Acad. Sci. USA 84: 4254 (10.1073/pnas.84.12.4254)
  5. Cowan, E. P., M. L. Jelachich, J. E. Coligan, W. E. Biddison. 1987. Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition. Proc. Natl. Acad. Sci. USA 84: 5014 (10.1073/pnas.84.14.5014)
  6. Plagemann, P. G. W.. 1991. Hepatitis C virus. Arch. Virol. 120: 165 (10.1007/BF01310473)
  7. Resnick, R. H., R. Koff. 1993. Hepatitis C-related hepatocellular carcinoma: prevalence and significance. Arch. Int. Med. 153: 1672 (10.1001/archinte.1993.00410140054007)
  8. Misiani, R., P. Bellavita, D. Fenili, O. Vicari, D. Marchesi, P. L. Sironi, P. Zilio, A. Vernocchi, M. Massazza, G. Vendramin, E. Tanzi, A. Zanetti. 1994. Interferon α-2a therapy in cryoglobulinemia associated with hepatitis C virus. N. Eng. J. Med. 330: 751 (10.1056/NEJM199403173301104)
  9. Thiele, D. L.. 1990. Implications of anti-hepatitis C reactivity in “autoimmune” chronic active hepatitis. Gastroenterology 99: 1531 (10.1016/0016-5085(90)91195-C)
  10. McFarlane, B. M., C. Bridger, C. J. Tibbs, M. G. Saleh, A. Fuzio, G. Verucchi, L. Attard, A. Boschi, F. Chiodo, I. G. McFarlane, R. Williams. 1994. Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J. Med. Virol. 42: 66 (10.1002/jmv.1890420113)
  11. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67: 2832 (10.1128/jvi.67.5.2832-2843.1993)
  12. Morgenstern, K. A., J. A. Landro, K. Hsiao, C. Lin, Y. Gu, M. S. Su, J. A. Thomson. 1997. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J. Virol. 71: 3767 (10.1128/jvi.71.5.3767-3775.1997)
  13. Jin, L., D. L. Peterson. 1995. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch. Biochem. Biophys. 323: 47 (10.1006/abbi.1995.0008)
  14. Hijikata, M., H. Mizushima, T. Akagi, S. Mori, N. Kakiuchi, N. Kato, T. Tanaka, K. Kimura, K. Shimotohno. 1993. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67: 4665 (10.1128/jvi.67.8.4665-4675.1993)
  15. Manabe, S., I. Fuke, O. Tanishita, C. Kaji, Y. Gomi, S. Yoshida, C. Mori, A. Takamizawa, I. Yosida, H. Okayama. 1994. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology 198: 636 (10.1006/viro.1994.1075)
  16. Shirai, M., T. Akatsuka, C. D. Pendleton, R. Houghten, C. Wychowski, K. Mihalik, S. Feinstone, J. A. Berzofsky. 1992. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J. Virol. 66: 4098 (10.1128/jvi.66.7.4098-4106.1992)
  17. Ferrari, C., A. Valli, L. Galati, A. Penna, P. Scaccaglia, T. Giuberti, C. Schianchi, G. Missale, M. G. Marin, F. Fiaccadori. 1994. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 19: 286 (10.1002/hep.1840190205)
  18. Botarelli, P., M. R. Brunetto, M. A. Minutello, P. Calvo, D. Unutmaz, A. J. Weiner, Q. L. Choo, J. R. Shuster, G. Kuo, F. Bonino, M. Houghton, S. Abrignani. 1993. T-lymphocyte responses to hepatitis C virus in different courses of infection. Gastroenterology 104: 580 (10.1016/0016-5085(93)90430-K)
  19. Eckels, D. D., P. Flomenberg, J. C. Gill. 1996. Hepatitis C virus: models of immunopathogenesis and prophylaxis. Transfusion 36: 836 (10.1046/j.1537-2995.1996.36996420765.x)
  20. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, et al 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369: 403 (10.1038/369403a0)
  21. Tabatabai, N., T. H. Bian, C. M. Rice, K. Yoshizawa, J. Gill, D. D. Eckels. 1999. Functionally distinct T-cell epitopes within the Hepatitis C Virus non-structural 3 protein. Hum. Immunol. 60: 105 (10.1016/S0198-8859(98)00102-5)
  22. Yoshioka, K., S. Kakumu, T. Wakita, T. Ishikawa, Y. Itoh, M. Takayanagi, Y. Higashi, M. Shibata, T. Morishima. 1992. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. Hepatology 16: 293 (10.1002/hep.1840160203)
  23. Grakoui, A., C. Wychowski, C. Lin, S. M. Feinstone, C. M. Rice. 1993. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67: 1385 (10.1128/jvi.67.3.1385-1395.1993)
  24. Smith, D. B., J. McAllister, C. Casino, P. Simmonds. 1997. Virus “quasispecies”: making a mountain out of a molehill?. J. Gen. Virol. 78: 1511 (10.1099/0022-1317-78-7-1511)
  25. Lundberg, K. S., D. D. Shoemaker, M. W. W. Adams, J. M. Short, J. A. Sorge, E. J. Mathur. 1991. High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosus. Gene 108: 1 (10.1016/0378-1119(91)90480-Y)
  26. Barnes, W. M.. 1992. The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion. Gene 112: 29 (10.1016/0378-1119(92)90299-5)
  27. Weiner, A. J., H. M. Geysen, C. Christopherson, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, et al 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89: 3468 (10.1073/pnas.89.8.3468)
  28. Bertoletti, A., A. Sette, F. V. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, C. Ferrari. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369: 407 (10.1038/369407a0)
  29. Archibald, A. L., N. A. Thompson, S. Kvist. 1986. A single nucleotide difference at the 3′ end of an intron causes differential splicing of two histocompatibility genes. EMBO J. 5: 957 (10.1002/j.1460-2075.1986.tb04309.x)
  30. Hughes, A. L., M. Nei. 1989. Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection. Proc. Natl. Acad. Sci. USA 86: 958 (10.1073/pnas.86.3.958)
  31. Martin, M. J., J. I. Nunez, F. Sobrino, J. Dopazo. 1998. A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus. J. Virol. Meth. 74: 215 (10.1016/S0166-0934(98)00088-3)
  32. Moore, K. W., A. O’Garra, M. R. de Waal, P. Vieira, T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165 (10.1146/annurev.iy.11.040193.001121)
  33. Eckels, D. D., N. Tabatabai, T.-H. Bian, H. Wang, S. S. Muheisen, C. M. Rice, K. Yoshizawa, and J. Gill. 1998. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation. Hum. Immunol. In press. (10.1016/S0198-8859(98)00111-6)
  34. Gooding, L. R.. 1992. Virus proteins that counteract host immune defenses. Cell 71: 5 (10.1016/0092-8674(92)90259-F)
Dates
Type When
Created 2 years, 8 months ago (Dec. 31, 2022, 10:20 p.m.)
Deposited 8 months ago (Jan. 2, 2025, 12:28 p.m.)
Indexed 3 months, 4 weeks ago (May 6, 2025, 12:47 a.m.)
Issued 26 years, 5 months ago (April 1, 1999)
Published 26 years, 5 months ago (April 1, 1999)
Published Print 26 years, 5 months ago (April 1, 1999)
Funders 0

None

@article{Wang_1999, title={Mutations in Immunodominant T Cell Epitopes Derived from the Nonstructural 3 Protein of Hepatitis C Virus Have the Potential for Generating Escape Variants That May Have Important Consequences for T Cell Recognition}, volume={162}, ISSN={1550-6606}, url={http://dx.doi.org/10.4049/jimmunol.162.7.4177}, DOI={10.4049/jimmunol.162.7.4177}, number={7}, journal={The Journal of Immunology}, publisher={Oxford University Press (OUP)}, author={Wang, Huiru and Eckels, David D.}, year={1999}, month=apr, pages={4177–4183} }